Oscar Health, Inc.OSCRNYSE
LOADING
|||
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +68.30% | +67.14% | +42.16% | +29.04% | +23.21% |
| Gross Profit Growth | +68.30% | +67.14% | +42.16% | +29.04% | +23.21% |
| EBITDA Growth | +0.00% | +0.00% | +56.58% | -396.10% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +61.48% | -483.17% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +55.20% | -506.29% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +42.86% | -470.83% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +53.33% | -594.44% | +0.00% |
| Weighted Average Shares Growth | +8.97% | +5.86% | +8.57% | +6.18% | +6.65% |
| Weighted Average Shares Diluted Growth | +8.97% | +17.07% | +4.13% | -11.09% | +6.65% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +16.83% | +38.49% | +2.40% | +0.00% |
| Free Cash Flow Growth | +0.00% | +16.93% | +38.37% | +2.08% | +0.00% |
| Receivables Growth | +45.17% | -36.10% | +17.84% | +4.77% | +48.19% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | +33.84% | +34.40% | +32.25% | +27.53% | +28.17% |
| Book Value per Share Growth | +16.05% | +19.10% | +18.97% | -4.15% | -17.42% |
| Debt Growth | +0.26% | +0.26% | +0.26% | +0.26% | +129.25% |
| R&D Expense Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| SG&A Expenses Growth | +41.04% | +445.01% | +22.31% | +22.83% | +13.51% |